نتایج جستجو برای: interferon beta 1

تعداد نتایج: 2915207  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1981
H Soreq A D Sagar P B Sehgal

Polyadenylylated mRNA was purified from poly(I).poly(C)- and cycloheximide-superinduced human fibroblast (FS-4) cultures. The mRNA was subjected to electrophoresis through an agarose/CH3HgOH gel, and human fibroblast beta 1 and beta 2 interferon mRNAs were isolated. Each mRNA preparation was phosphorolyzed at 0 degrees C for 20 min by using a molar excess of polynucleotide phosphorylase to prod...

Journal: :Folia neuropathologica 2004
Adam Szczuciński Jacek Losy

Chemokines play an important role in pathogenesis of multiple sclerosis (MS), mediating migration of leukocytes into the central nervous system. CCL2 (MCP-1) chemokine is expressed in astrocytes in MS lesions. The aim of the study was to evaluate the effect of a two-year treatment with IFN-beta 1a on serum CCL2 level in MS patients. CCL2 concentration in sera of 18 relapsing-remitting MS (RR-MS...

2009
Thomas Hansen David New Roy Reeve Rosemary Donne William Stephens

We report a man with type 1 diabetes mellitus, autoimmune hypothyroidism and a tentative diagnosis of multiple sclerosis. Following treatment with beta interferon, he developed systemic lupus erythematosus with pericarditis, pleural effusions, cerebral infarction associated with anti-phospholipid antibody and acute renal failure due to thrombotic microangiopathy. He responded well to immunosupp...

Journal: :Archives of neurology 2007
Frederik Barkhof Chris H Polman Ernst-Wilhelm Radue Ludwig Kappos Mark S Freedman Gilles Edan Hans-Peter Hartung David H Miller Xavier Montalbán Peter Poppe Marlieke de Vos Fatiha Lasri Lars Bauer Susanne Dahms Klaus Wagner Christoph Pohl Rupert Sandbrink

BACKGROUND In the Betaseron/Betaferon in Newly Emerging Multiple Sclerosis for Initial Treatment (BENEFIT) study, interferon beta-1b delayed conversion to multiple sclerosis in patients with a first clinical event and at least 2 clinically silent brain magnetic resonance imaging (MRI) lesions. OBJECTIVE To examine detailed MRI findings from the first 2 years of this trial. DESIGN Double-bli...

Journal: :iranian journal of neurology 0
maryam kay msc student, department of biology, school of sciences, university of isfahan, isfahan, iran. zohreh hojati assistant professor, department of biology, school of sciences, university of isfahan, isfahan, iran fariba dehghanian msc student, department of biology, school of sciences, university of isfahan, isfahan, iran

multiple sclerosis (ms) is one of the most important autoimmune diseases recognized by demyelination and axonal lesion. it is the most common cause of disability in the young population. various immunomodulatory and immunosuppressive therapies, including different formulations of interferon beta (ifnβ), glatiramer acetate (ga), mitoxantrone, and natalizumab are available for this disease. howev...

Journal: :jundishapur journal of microbiology 0
ashraf mohamadkhani liver and pancreatobiliary diseases research center, digestive diseases research institute, tehran university of medical sciences, tehran, iran sima besharat golestan research center of gastroentrology and hepatology, golestan university of medical sciences, gorgan, iran golnosh gol-jah rad liver and pancreatobiliary diseases research center, digestive diseases research institute, tehran university of medical sciences, tehran, iran akbar pour dadash asiabar microbiology laboratory, dr. shariati hospital, tehran, iran gholamreza roshandel golestan research center of gastroentrology and hepatology, golestan university of medical sciences, gorgan, iran akram pourshams liver and pancreatobiliary diseases research center, digestive diseases research institute, tehran university of medical sciences, tehran, iran

conclusions these findings indicated the association of the hbsag titer and serum ifnar2 in hbsag clearance in hepatitis b virus- infected patients. in consequence, immune mechanisms related to ifn-α/β signaling might be responsible in chb outcome. background loss of hepatitis b surface antigen (hbsag) in chronic hepatitis b (chb) infection is a favorable outcome. type i interferon (ifni) has a...

Journal: :Journal of virology 2006
Peter J Alff Irina N Gavrilovskaya Elena Gorbunova Karen Endriss Yuson Chong Erika Geimonen Nandini Sen Nancy C Reich Erich R Mackow

Hantaviruses cause two diseases with prominent vascular permeability defects, hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. All hantaviruses infect human endothelial cells, although it is unclear what differentiates pathogenic from nonpathogenic hantaviruses. We observed dramatic differences in interferon-specific transcriptional responses between pathogenic and nonpa...

Journal: :The Journal of biological chemistry 1994
S T Whiteside P King S Goodbourn

The interferon-beta promoter binding protein, IRF-2, is proteolytically processed during induction by double-stranded RNA to leave an N-terminal fragment that can still bind to DNA. An N-terminal fragment that corresponds to the induction-specific product has a higher affinity for the promoter and is a more potent repressor of interferon-beta transcription than the full-length precursor. The ki...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید